Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. - Wikidata - wikimedia - TriplyDB

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

http://www.wikidata.org/entity/Q35007847

about

Mesenchymal stem cells in regenerative rehabilitation Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic Stroke Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies The Dark Side of the Force - Constraints and Complications of Cell Therapies for Stroke Stem cell therapy for acute cerebral injury: what do we know and what will the future bring?Stem cell treatment for Alzheimer's disease Cell based therapies for ischemic stroke: from basic science to bedside Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?Adult Stem Cell Therapy for Stroke: Challenges and Progress Developing Cellular Therapies for Stroke Mesenchymal Stem Cells Attenuate NADPH Oxidase-Dependent High Mobility Group Box 1 Production and Inhibit Abdominal Aortic Aneurysms.Diabetes-associated macrovascular complications: cell-based therapy a new tool?MRI stem cell tracking for therapy in experimental cerebral ischemia.Establishment of a mesenchymal stem cell bank.Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.Endothelial progenitor cells: therapeutic perspective for ischemic stroke.Blood Pressure and Penumbral Sustenance in Stroke from Large Vessel Occlusion.Comparison of Nutech Functional Score with European Stroke Scale for Patients with Cerebrovascular Accident Treated with Human Embryonic Stem Cells: NFS for CVA Patients Treated with hESCs Mesenchymal Stem Cells Overexpressing Interleukin-10 Promote Neuroprotection in Experimental Acute Ischemic Stroke.Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells.Transplanted bone marrow stromal cells protect neurovascular units and ameliorate brain damage in stroke-prone spontaneously hypertensive rats.Stem cell therapy for cerebral ischemia: from basic science to clinical applications.Stem cell therapy: a new approach to the treatment of refractory depression.Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.Robotics, stem cells, and brain-computer interfaces in rehabilitation and recovery from stroke: updates and advances.Stem cell-based treatments against stroke: observations from human proof-of-concept studies and considerations regarding clinical applicability.Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices.Intra-Arterial Immunoselected CD34+ Stem Cells for Acute Ischemic Stroke.Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice.Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.Transplantation of Unique Subpopulation of Fibroblasts, Muse Cells, Ameliorates Experimental Stroke Possibly via Robust Neuronal Differentiation.Efficacy and safety of stem cell therapies for patients with stroke: a systematic review and single arm meta-analysis.Human bone marrow mesenchymal stem cell transplantation attenuates axonal injury in stroke rats.Cortical neurogenesis in adult rats after ischemic brain injury: most new neurons fail to mature.The cerebral embolism evoked by intra-arterial delivery of allogeneic bone marrow mesenchymal stem cells in rats is related to cell dose and infusion velocity Differential Migration of Mesenchymal Stem Cells to Ischemic Regions after Middle Cerebral Artery Occlusion in Rats.Mesenchymal stem/stromal cells-a key mediator for regeneration after perinatal morbidity?Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients

P2860

Q26743836-0BFB2A67-7A4F-4B00-8396-0A1C60F73E2C Q26746977-78E1BF5F-0F57-42F1-9778-B219380A4791 Q26776494-49291815-8AE2-4358-A0DA-60F9B4E1FE01 Q26799107-850A93E2-DD88-483A-88F4-762C4EE3EA2F Q26800181-A27FBE08-16D6-4222-8CCD-863CBBD674F3 Q26866149-6CD66D49-A9F7-48EF-8C72-F654C49987DA Q27007013-0063A8AC-B5F7-47C4-BC4C-13730F802966 Q27025754-DCEBB412-948B-4E70-B3C3-37DB33E16049 Q27692601-38C31F03-0932-44EE-A723-AC79F0579DA7 Q28066235-24F73130-3FA2-4E96-AC2F-7AA3C9236F27 Q28087451-C7222BDD-9D9E-4173-8B92-B0892C829AA5 Q30277137-F2EB7432-44ED-46FF-93AF-35EDCC50C74F Q30428895-B3DF8BFA-325C-4350-9118-CBDF6BED083D Q30712193-EF1B6DCB-59C8-4989-B7B5-2AC2AA325FA0 Q33453904-71A212D6-C2EF-4CE4-809E-E92515BC8A2E Q33592708-1B9204B9-9170-41EB-83A5-FC70E079B83C Q33705402-EFCF09F2-E812-4F1B-840D-ABD897ED67F7 Q33863549-BA0EF389-6088-4CDD-9564-7B4B83A69F6B Q33882998-8E89F825-BC95-4E4E-84C9-1E6AB6319466 Q33887223-AB2E9F29-1B31-4FDA-AF39-8E8F4BA82B2E Q34062490-4EE2D19B-68D8-4D12-ACFE-ED8C7C082F12 Q34125531-DBB8F8EB-73CE-499D-B630-AC18EAC1A3D0 Q34129832-BBDBC006-3E77-4575-8786-46744D2364CA Q34215946-28E4BD7A-0A5A-441B-B803-5E9A4EEEF5AA Q34240433-5064DAFA-69C8-428C-A39D-DEF208B4070E Q34340851-81B54959-35F8-490E-B855-EFCAB9F0FC52 Q34419548-1080DEAC-EFBA-48EC-AD27-90FB418C7BB5 Q34422955-C21E5A9A-11C9-4C6B-8DD8-E8E3D2C2FE0F Q34428957-BBCB1A18-D513-4F8C-9108-F5DA0F7D1D50 Q34432396-32E27B32-0191-4A96-9E09-494064690BDB Q34469147-50E47C84-C0A2-4710-9C63-D765B169F82D Q34494917-D143F8CD-6D81-4C91-B060-F936A4864077 Q34599756-5576D935-DFCF-4CCE-BF41-2500D8CB05F8 Q35046996-DDB2A617-0014-4133-B540-05D5E04F3A1D Q35356980-81C81206-1E8E-489B-8A40-32E49657E089 Q35631025-6B20A5A9-7287-4A68-A4F7-07801F298D2D Q35737488-AA37BF14-0981-47D8-855B-D78AB7E8608E Q35921652-960100F5-E978-490D-9F02-45B9BC700270 Q36067866-CE17BDC0-E07F-4E85-A802-41445C4A02A4 Q36092131-C0B63B29-2DA2-4619-9569-1C6E30970519

P2860

Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.

http://www.wikidata.org/entity/Q35007847

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Intravenous administration of ...... enchymal stem cells in stroke.

@ast

Intravenous administration of ...... enchymal stem cells in stroke.

@en

type

label

Intravenous administration of ...... enchymal stem cells in stroke.

@ast

Intravenous administration of ...... enchymal stem cells in stroke.

@en

prefLabel

Intravenous administration of ...... enchymal stem cells in stroke.

@ast

Intravenous administration of ...... enchymal stem cells in stroke.

@en

P1433

Q35007847-B7AD42A7-BE7A-40CE-89C3-0E27865BD5AB

P1476

Q35007847-CFCF7438-96DA-458D-9A3A-59E4FD51BA77

P2093

Q35007847-06D79D9D-16F4-480A-AF59-C26B3D1C0E21

Q35007847-0FB4AD2B-C0EF-4A07-A97B-0CC4B386B1D9

Q35007847-283A4B2F-32DC-4F24-9B1A-A13614279FDB

Q35007847-2CBE9F3E-1390-48BC-9B39-C7CFF51F8996

Q35007847-37743AAC-0C53-4ECA-B0DC-98377BCB99F8

Q35007847-9DCD2744-8469-4039-9C30-7568F57AFE9F

Q35007847-A1A8D383-DAC4-439F-99AD-606EF9518527

Q35007847-D3146F33-B4D9-4469-8AE9-0C42A1033BD5

P2860

Q35007847-27D40373-88BC-4C5D-9AD3-7178181350B2

Q35007847-28E9FCFA-7EFA-4B14-8005-4E71A7C88E5F

Q35007847-2A08DEA9-E074-4E63-8C00-4A38C89E24C1

Q35007847-2A47B7F0-C967-4EF6-9EC5-38AE98E64D95

Q35007847-33042FAF-4D56-4BF1-A729-026316CA0A82

Q35007847-3EF263EA-D5B7-4D75-A4A4-1D9113BD83D0

Q35007847-433D3BA8-EB20-4DE5-A874-9F5B7C727C32

Q35007847-56542FBB-D46D-4744-9A4B-B70877E117AD

Q35007847-5D2DA9C1-89FA-45D7-9CE2-E0194E507512

Q35007847-5FC4576E-537A-456B-A9DB-E9CBD1C59AC0

P304

Q35007847-9A73DCD2-14BC-4EA4-9C78-1C766F19FE72

P31

Q35007847-87036AC2-80E7-47CE-9676-8FAA7AC78593

P356

Q35007847-BA7B7359-18AE-47A6-9465-ECB83EF56DC0

P407

Q35007847-347BA724-E5BA-4F93-8A38-BADBB99A5E72

P433

Q35007847-BC089F98-19A0-44B2-BCEF-2377CB764017

P478

Q35007847-C3959316-0828-4DF3-AB5B-0FBC58F6B651

P577

Q35007847-7767273E-BF5E-4105-B595-EBFA97F49977

P5875

Q35007847-C66AC473-8731-4599-A1BF-A77A52298ABB

P698

Q35007847-43B4D3C5-9A04-406A-B3CF-A62B755C85DD

P932

Q35007847-1D1B4DF3-79B0-43FA-822A-E6AE42F16ECA

P356

P1433

P1476

Intravenous administration of ...... enchymal stem cells in stroke.

@en

P2093

Jeffery D Kocsis

http://www.w3.org/2001/XMLSchema#string

Kiyohiro Houkin

http://www.w3.org/2001/XMLSchema#string

Osamu Honmou

http://www.w3.org/2001/XMLSchema#string

Rie Onodera

http://www.w3.org/2001/XMLSchema#string

Stephen G Waxman

http://www.w3.org/2001/XMLSchema#string

Sumio Ishiai

http://www.w3.org/2001/XMLSchema#string

Takuya Matsunaga

http://www.w3.org/2001/XMLSchema#string

Yoshiro Niitsu

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia

Adult rat and human bone marrow stromal cells differentiate into neurons

Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease

Marrow stromal cells as stem cells for nonhematopoietic tissues

Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat

Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats.

TrkB activation by brain-derived neurotrophic factor inhibits the G protein-gated inward rectifier Kir3 by tyrosine phosphorylation of the channel.

Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study.

Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.

Autologous mesenchymal bone marrow stem cells: practical considerations.

P304

1790-1807

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWR063

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 6

http://www.w3.org/2001/XMLSchema#string

P478

134

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51051843

http://www.w3.org/2001/XMLSchema#string

P698

21493695

http://www.w3.org/2001/XMLSchema#string

P932

3102237

http://www.w3.org/2001/XMLSchema#string